Leukocare and Sanofi Pasteur Sign Cooperation Agreement

Monday, July 25th, 2011

Leukocare AG, a privately-owned specialist company for protein stabilisation and biological surface coating from Munich, Germany, today announced the signing of a cooperation agreement with Sanofi Pasteur, the vaccines division of Sanofi. As part of this cooperation, Sanofi Pasteur will explore Leukocare’s SPS platform technology to enhance the shelf-life of ...

Medtech World News: Of Fruit Pies and Biofunctionalised Coatings

Monday, January 31st, 2011

When Julian Hergenröther of Leukocare (Martinsried, Germany) and I met years ago working student jobs before joining the real world, neither of us knew that we would bump into each other again several years later. But there he is—a biotechnical engineer writing an article about the latest technologies ...

Leukocare Signs Cooperation Agreement with Sterigenics

Thursday, November 25th, 2010

Leukocare AG, a privately owned company developing innovative life science technologies, announced the signing of a cooperation agreement with Sterigenics, a global sterilisation services provider. As part of this cooperation, Leukocare plans to use their Stabilising and Protecting Solutions (SPS) technology together with Sterigenics’ irradiation expertise to establish new sterilisation ...

Leukocare Receives Certification to ISO 9001 and ISO 13485

Wednesday, February 24th, 2010

Leukocare AG, a privately owned company that develops  biofunctional surfaces using proprietary stabilising postcoating technology, announced today that it has established a quality management system (QMS) in accordance with ISO 9001:2008 and ISO 13485:2003 standards for medical devices. To achieve certification to the ISO standards, the company implemented a QMS for ...

BIOMEDevice: Leukocare’s Postcoating Stabilisation Technology Preserves Biomolecular Functionality

Sunday, February 7th, 2010

Think of it as the confection that holds together a fruitcake. That is how Michael Scholl, CEO of Leukocare, described his company’s surface functionalisation and binding technology to BIOMEDevice Europe attendees. It was one of several papers presented under the thematic umbrella of Enabling Technologies for Manufacturing Combination Products at ...